APG-1252 (Pelcitoclax)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for APG-1252 (Pelcitoclax), covering 2026-04-13 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Testing the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial Cancers [Phase 1]